11C-labeled methionine and evaluation of malignant pleural mesothelioma [13]

New England Journal of Medicine

Volumn 357, Issue 19, 2007, Pages 1982-1984

  Ceresoli, Giovanni L ^a   Chiti, Arturo ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CARBON 11; CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; LAT PROTEIN; METHIONINE; PEMETREXED; RADIOPHARMACEUTICAL AGENT; CARBON; DIAGNOSTIC AGENT;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; LETTER; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MEASUREMENT; NEUROIMAGING; PLEURA MESOTHELIOMA; PLEURODESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; MESOTHELIOMA; METABOLISM; MIDDLE AGED; PLEURA TUMOR;

CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MESOTHELIOMA; METHIONINE; MIDDLE AGED; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35848938173     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc071823     Document Type: Letter

References (5)

1. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004;15:257-60.
2. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354:496-507.
3. Ceresoli GL, Chiti A, Zucali PA, et al. Early evaluation in malignant pleural mesothelioma by positron emission tomography with [18F] fluorodeoxyglucose. J Clin Oncol 2006;24:4587-93.
4. Carretta A, Landoni C, Melloni G, et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. Eur J Cardiothorac Surg 2000;17:377-83.
5. Jager PL, Vaalburg W, Pruim J, de Vries FG, Langen KJ. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-45.